First-line pembrolizumab monotherapy met the primary end point of PFS in dMMR advanced/recurrent endometrial cancer.
|Videos|May 10, 2011
Facilitating Intraperitoneal Chemotherapy Completion
Author(s)Fiona McCaughan, RN, MS
Fiona McCaughan on Nurses Facilitating Intraperitoneal Chemotherapy Completion
Advertisement
Fiona McCaughan, RN, MS, OCN® of Hematology Oncology at Winchester Hospital on Nurses Facilitating Intraperitoneal Chemotherapy Completion
Advertisement
Related to this article
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
Dr Falchi on Critical Unmet Needs and Important Next Steps in DLBCL
4
Olverembatinib Plus Blinatumomab Yields High Early-Phase CR/CRi Rates in R/R Ph+ CML and B-ALL
5